Financial Advocates Investment Management’s Celgene Corp CELG Stock Holding History

Financial Advocates Investment Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,907	Closed	-$288K	–	547
2019 Q3	$288K	Buy	+2,907	New	+$276K	0.03%	384
2019 Q2	–	Sell	-3,487	Closed	-$331K	–	493
2019 Q1	$329K	Buy	+3,487	New	+$305K	0.04%	348
2018 Q4	–	Sell	-3,463	Closed	-$310K	–	526
2018 Q3	$310K	Buy	+3,463	New	+$306K	0.03%	382

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Financial Advocates Investment Management's CELG Position: Q4 2019 in Review

Financial Advocates Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,907 shares — an estimated $288K sold.

Financial Advocates Investment Management first reported a position in CELG in Q3 2018 and held it in 3 quarters. The position peaked at $329K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Financial Advocates Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Financial Advocates Investment Management sold 2,907 Celgene Corp shares in Q4 2019, an estimated $288K.
Financial Advocates Investment Management first reported a position in Celgene Corp in Q3 2018 and held it in 3 quarters.
Financial Advocates Investment Management's Celgene Corp position peaked at $329K in Q1 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Financial Advocates Investment Management's 13F filing for Q4 2019, filed 13 Feb 2020.